跳至主要内容
临床试验/EUCTR2014-003581-25-DE
EUCTR2014-003581-25-DE进行中(未招募)1 期

Anti-inflammatory pulmonal therapy of CF-patients with Amitriptyline and Placebo - Randomised, double-blind, placebo-controlled cohort trial

niversity Hospital Tuebingen0 个研究点目标入组 102 人开始时间: 2014年12月15日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
102

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1.Cystic Fibrosis is verified;
  • 2.Patient is older than 12 years;
  • 3.Patients weight is more than 35 kg;
  • 4.FEV1 is higher than 25% and lower than 100% (two times in 3 months);
  • 5.The patients lung is colonised with bacteria;
  • 6.No acute pulmonal illness is present;
  • 7.Lung function testing is possible;
  • 8.A full course of therapy is possible without any restrictions;
  • 9.Informed consent is given.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 15
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 87
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • 1.FEV1 in screening and baseline differs more than 10%;
  • 2.Clinicial detoriation is present (exacerbation symptoms);
  • 3.Change of CRP of more than 50% in screening period;
  • 4.Glaucoma, seizures, heart insufficiency or major depression is pre-sent;
  • 5.Intravenous antibiotic treatment was necessary for the last 2 weeks prior to the trial;
  • 6.High dose steroid therapy;
  • 7.On-therapy of tobramycine in the last 2 weeks;
  • 8.Involvement of the patient in another study;
  • 9.Pregnancy.

研究者

发起方
niversity Hospital Tuebingen

相似试验